sRANK Ligand Antibody | 3963

sRANK Ligand Antibody | 3963 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse, Rat

Homology: N/A

Immunogen: Anti-sRANK-L antibody (3963) was raised against a peptide corresponding to 14 amino acids near the center of human sRANK-L.
The immunogen is located within amino acids 140-190 of sRANK-L.

Research Area: Apoptosis

Tested Application: E, WB, IHC-P

Application: WB: 0.25-4 μg/mL; IHC: 5 μg/mL.
Antibody validated: Western Blot in human, mouse and rat samples; Immunohistochemistry in human and rat samples. All other applications and species not yet tested.

Specificiy: N/A

Positive Control 1: Cat. No. 1464 - Rat Liver Tissue Lysate

Positive Control 2: Cat. No. 1304 - Human Liver Tissue Lysate

Positive Control 3: Cat. No. 10-201 - Human Liver Tissue Slide

Positive Control 4: Cat. No. 1404 - Mouse Liver Tissue Lysate

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: Predicted: 36kD
Observed: 36 kD

Validation:

Recombinant Protein Test (Figure 3) : Anti-sRANK-L antibodies (3963) detected human sRANK-L recombinant protein at different concentrations.

Induced expression validation (Figure 6) : sRANK-L expression detected by anit-sRANK-L antibodies (3963) was up-regulated after 18hr by extraction of  upper jaw molars in rat osteogenic cells.

Isoform: Human sRANK-L has 3 isoforms, including isoform 1 (317aa, 35.5kD) , isoform 2 (244aa, 27.7kD) and isoform 3 (270aa, 30.5kD) . Mouse sRANK-L also has 3 isoforms, including isoform 1 (316aa, 35kD) , isoform 2 (287aa, 32.3kD) and isoform 3 (199aa, 22.2kD) . Rat sRANK-L has one isoform (318aa, 38.4kD) . 3963 can detect human, mouse and rat.

Purification: sRANK Ligand Antibody is affinity chromatography purified via peptide column.

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: sRANK Ligand Antibody is supplied in PBS containing 0.02% sodium azide.

Concentration: 1 mg/mL

Storage Condition: sRANK Ligand antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Alternate Name: sRANK Ligand Antibody: ODF, OPGL, sOdf, CD254, OPTB2, RANKL, TRANCE, hRANKL2, Tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, ODF

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: sRANK Ligand Antibody: The receptor activator of NF-κB ligand (RANK-L) is a recently discovered member of the TNF-ligand family involved in the regulation of the T cell-dependent immune response, lymph node organogenesis and bone formation. RANK-L exists as both a normal, transmembrane form and a truncated, soluble form (sRANK-L) , both of which can stimulate the receptor. Activation of T cells, such as by treatment with interleukin-7, induces RANK-L production and leads to an increase of osteoclast formation and bone loss. Finally, sRANK-L can activate the antiapoptotic kinase Akt through a signaling complex involving Src kinase and TRAF6, suggesting sRANK-L may also play a role in regulating apoptosis. This antibody will recognize both the soluble form and the uncleaved transmembrane form of RANK-L.